AstraZeneca prostate cancer drug Lynparza shows promise Medical Dialogues Bureau2 Oct 2019 9:35 AM ISTAnalysts see AstraZeneca and Merck's Lynparza leading the PARP inhibitor class with an average sales estimate of $3.1 billion for 2023. Rival...
Bayer to improve disease diagnosis, drug design via use of AI Medical Dialogues Bureau2 Oct 2019 9:32 AM ISTGermany's Bayer has been testing how the technology can help diagnose complex or rare conditions, hasten drug development and more.New Delhi:...
4 websites get USFDA warning letter for selling illegal opioid medicines Farhat Nasim2 Oct 2019 9:30 AM ISTThe networks which were issued the warning letters by USFDA and DEA on Monday for illegally marketing unapproved and misbranded versions of opioid...
Bangladesh BANS import of raw materials, production, sale of RANITIDINE over cancer fears Medical Dialogues Bureau2 Oct 2019 9:15 AM ISTDrug manufacturers across the world have begun recalling the widely taken heartburn drug, which is sold under the trade name Zantac among others,...
Pharmacokinetic study of Avastin: Cadila to submit revised protocol to CDSCO committee Farhat Nasim1 Oct 2019 4:09 PM ISTNew Delhi: The apex drug regulatory body, Central Drug Standard Control Organisation's (CDSCO) Subject Expert Committee (SEC) recently recommended...
Natco Pharma Mekaguda facility gets EIR from USFDA Farhat Nasim1 Oct 2019 3:57 PM ISTHyderabad: Drug firm Natco Pharma today said it has received Establishment Inspection Report (EIR) from the US health regulator for its Active...
Cadila Healthcare to sell right of cholesterol-lowering drug Zypitamag for Rs 49 crore Farhat Nasim1 Oct 2019 2:13 PM ISTThe company has entered into an asset purchase agreement to sell its right, title and interest in Zypitamag, along with applicable registrations and...
Lupin unveils generic version of Viagra in US Medical Dialogues Bureau1 Oct 2019 1:32 PM ISTLupin’s Sildenafil Tablets USP, 25 mg, 50 mg, and 100 mg, is the generic version of Pfizer Inc’s Viagra Tablets, 25 mg, 50 mg, and 100 mg. Mumbai:...
Setback: AstraZeneca fails to win USFDA nod for combo lung disease therapy Farhat Nasim1 Oct 2019 10:00 AM ISTThe setback comes as AstraZeneca tries to catch up with domestic rival GlaxoSmithKline's Trelegy, which is delivered through inhaler Ellipta. That...
Glenmark wins Russian Health Ministry nod for allergic rhinitis drug Montlezir Farhat Nasim30 Sept 2019 3:29 PM ISTGlenmark Pharma's allergic rhinitis drug Montlezir is expected to be available in the Russian market in Q3 FY 2019‐20.Mumbai: Glenmark Pharmaceuticals...
Cipla gets 12 USFDA observations for Goa facility Medical Dialogues Bureau30 Sept 2019 3:15 PM IST"The United States Food and Drug Administration (USFDA) conducted a cGMP inspection at our Goa manufacturing facility from September 16-27, 2019,"...
Glenmark Pharma to raise Rs 1413 crore via debt securities Medical Dialogues Bureau30 Sept 2019 3:03 PM ISTAccording to the proposal, Glenmark Pharma plans to raise up to $ 200 million in Indian and/or international market through bonds, debentures or other...
